SCHEMBL17864015

SCHEMBL17864015

CC(=O)OC1C[C@]2(O)C3CCC4CC(O)CCC4(C)C3CCC2(C)C1C1=CC(=O)OC1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 5/20 0.84
SMN1; SMN2 Q16637 3/20 0.84
RAB9A P51151 4/20 0.77
CYP2C19 P33261 2/20 0.77
ATP1A1 P05023 4/20 0.65
ATP1B1 P05026 4/20 0.65
ATP1A3 P13637 4/20 0.65
ATP1B2 P14415 4/20 0.65
ATP1A2 P50993 4/20 0.65
ATP1B3 P54709 4/20 0.65
FXYD2 P54710 4/20 0.65
ATP1A4 Q13733 4/20 0.65
PAX8 Q06710 3/20 0.65
NPC1 O15118 3/20 0.65
LMNA P02545 2/20 0.65
HIF1A Q16665 2/20 0.65
CYP3A4 P08684 1/20 0.65
TSHR P16473 1/20 0.65
ATP12A P54707 1/20 0.65
HSD17B10 Q99714 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905625 1.00 TP53 (0.84) TP53SMN1; SMN2RAB9ACYP2C19ATP1A1
Gitoxigenin Diacetate SCHEMBL30631700 0.92 TP53 (1.00) TP53SMN1; SMN2RAB9ACYP2C19ATP1A1
SCHEMBL21833930 0.89 TP53 (0.77) TP53SMN1; SMN2RAB9ACYP2C19ATP1A1
SCHEMBL17505652 0.89 TP53 (0.77) TP53SMN1; SMN2RAB9ACYP2C19ATP1A1
SCHEMBL15527657 0.89 TP53 (0.77) TP53SMN1; SMN2RAB9ACYP2C19ATP1A1
SCHEMBL15526997 0.89 TP53 (0.77) TP53SMN1; SMN2RAB9ACYP2C19ATP1A1
SCHEMBL15527660 0.89 TP53 (0.77) TP53SMN1; SMN2RAB9ACYP2C19ATP1A1
SCHEMBL20814628 0.88 TP53 (0.86) TP53SMN1; SMN2RAB9ACYP2C19ATP1A1
SCHEMBL20814570 0.88 TP53 (0.86) TP53SMN1; SMN2RAB9ACYP2C19ATP1A1
SCHEMBL18677958 0.88 TP53 (0.86) TP53SMN1; SMN2RAB9ACYP2C19ATP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160176914-A1 GLYCOSYLATED CARDIOTONIC STEROIDS NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR NIH 2016-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160176914-A1 GLYCOSYLATED CARDIOTONIC STEROIDS NR3C2, NR5A1, CYP11B1 TP53 4882/4885SMN1; SMN2 4237/4885RAB9A 4722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.